Pain and Inflammation Research

Although separate conditions, pain and inflammation are nearly always associated with each other. Pain is defined by the International Association for the Study of Pain (IASP) as 'an unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage'. Inflammation is the tissue's immunologic response to injury, characterized by mobilization of white blood cells and antibodies, swelling, and fluid accumulation.

Pain and Inflammation Research Products Areas

Products for Pain and Inflammation Research - Page 52

Cat.No. Product Name Information/Activity
BCC6182 SEN 12333 874450-44-9
BCC7394 TC 1698 dihydrochloride 787587-06-8
BCC7264 α-Bungarotoxin 11032-79-4
BCC1047 COG 133 ApoE peptide fragment; <span class='symbol'>α</span>7 nAChR antagonist
BCC5974 α-Conotoxin ImI 156467-85-5
BCC6897 Methyllycaconitine citrate 112825-05-5
BCC7028 MG 624 77257-42-2
BCC4027 Tropisetron Hydrochloride Tropisetron Hydrochloride (SDZ-ICS-930) is a selective 5-HT3 receptor antagonist and α7-nicotinic receptor agonist with an IC50 of 70.1 ± 0.9 nM for 5-HT3 receptor.
BCC1324 A-867744 A-867744 is a highly potent and selective type II positive allosteric modulator (PAM) of the alpha7 nicotinic acetylcholine receptors (nAChR) with an EC50 of 1.0 μM.
BCC7788 CCMI CCMI is a potent and selective α7 nAChR-positive allosteric modulator, does not bind to or activate α7 nAChRs via the orthosteric site, and causes significant positive modulation of agonist-induced currents at α7 nAChRs. CCMI has potential in CNS diseases with cognitive dysfunction.